Mayer-Barber Katrin D, Yan Bo
Inflammation and Innate Immunity Unit, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Cell Mol Immunol. 2017 Jan;14(1):22-35. doi: 10.1038/cmi.2016.25. Epub 2016 Jun 6.
Over the past decades the notion of 'inflammation' has been extended beyond the original hallmarks of rubor (redness), calor (heat), tumor (swelling) and dolor (pain) described by Celsus. We have gained a more detailed understanding of the cellular players and molecular mediators of inflammation which is now being applied and extended to areas of biomedical research such as cancer, obesity, heart disease, metabolism, auto-inflammatory disorders, autoimmunity and infectious diseases. Innate cytokines are often central components of inflammatory responses. Here, we discuss how the type I interferon and interleukin-1 cytokine pathways represent distinct and specialized categories of inflammatory responses and how these key mediators of inflammation counter-regulate each other.
在过去几十年里,“炎症”的概念已超越了塞尔苏斯所描述的发红、发热、肿胀和疼痛这些最初特征。我们对炎症的细胞参与者和分子介质有了更详细的了解,目前这些了解正被应用并扩展到生物医学研究领域,如癌症、肥胖症、心脏病、新陈代谢、自身炎症性疾病、自身免疫性疾病和传染病。天然细胞因子通常是炎症反应的核心组成部分。在此,我们将讨论I型干扰素和白细胞介素-1细胞因子途径如何代表不同且特殊的炎症反应类别,以及这些关键的炎症介质如何相互拮抗。